Johnson Investment Counsel’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-62,460
| Closed | -$180K | – | 671 |
|
2021
Q3 | $180K | Hold |
62,460
| – | – | ﹤0.01% | 630 |
|
2021
Q2 | $237K | Hold |
62,460
| – | – | ﹤0.01% | 577 |
|
2021
Q1 | $211K | Hold |
62,460
| – | – | ﹤0.01% | 579 |
|
2020
Q4 | $175K | Hold |
62,460
| – | – | ﹤0.01% | 576 |
|
2020
Q3 | $157K | Buy |
62,460
+500
| +0.8% | +$1.26K | ﹤0.01% | 556 |
|
2020
Q2 | $841K | Buy |
+61,960
| New | +$841K | 0.02% | 312 |
|
2020
Q1 | – | Sell |
-76,141
| Closed | -$481K | – | 532 |
|
2019
Q4 | $481K | Hold |
76,141
| – | – | 0.01% | 422 |
|
2019
Q3 | $298K | Hold |
76,141
| – | – | 0.01% | 501 |
|
2019
Q2 | $368K | Hold |
76,141
| – | – | 0.01% | 476 |
|
2019
Q1 | $623K | Buy |
76,141
+14,679
| +24% | +$120K | 0.01% | 377 |
|
2018
Q4 | $339K | Hold |
61,462
| – | – | 0.01% | 460 |
|
2018
Q3 | $542K | Hold |
61,462
| – | – | 0.01% | 423 |
|
2018
Q2 | $613K | Sell |
61,462
-105
| -0.2% | -$1.05K | 0.02% | 399 |
|
2018
Q1 | $586K | Buy |
61,567
+105
| +0.2% | +$999 | 0.02% | 388 |
|
2017
Q4 | $913K | Sell |
61,462
-1,000
| -2% | -$14.9K | 0.02% | 288 |
|
2017
Q3 | $1.23M | Sell |
62,462
-859
| -1% | -$16.9K | 0.03% | 222 |
|
2017
Q2 | $909K | Sell |
63,321
-2,071
| -3% | -$29.7K | 0.03% | 268 |
|
2017
Q1 | $601K | Buy |
65,392
+2,930
| +5% | +$26.9K | 0.02% | 339 |
|
2016
Q4 | $650K | Sell |
62,462
-37,303
| -37% | -$388K | 0.02% | 307 |
|
2016
Q3 | $902K | Buy |
99,765
+2,930
| +3% | +$26.5K | 0.03% | 236 |
|
2016
Q2 | $724K | Buy |
96,835
+2,930
| +3% | +$21.9K | 0.02% | 267 |
|
2016
Q1 | $846K | Buy |
93,905
+2,930
| +3% | +$26.4K | 0.03% | 239 |
|
2015
Q4 | $1.18M | Sell |
90,975
-7,026
| -7% | -$90.7K | 0.04% | 197 |
|
2015
Q3 | $946K | Buy |
98,001
+22,613
| +30% | +$218K | 0.03% | 220 |
|
2015
Q2 | $775K | Buy |
+75,388
| New | +$775K | 0.03% | 246 |
|